These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17898257)

  • 1. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker.
    Barak V; Frenkel S; Valyi-Nagy K; Leach L; Apushkin MA; Lin AY; Kalickman I; Baumann NA; Pe'er J; Maniotis AJ; Folberg R
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4399-402. PubMed ID: 17898257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamics of serum tumor markers in predicting metastatic uveal melanoma (part 1).
    Barak V; Kaiserman I; Frenkel S; Hendler K; Kalickman I; Pe'er J
    Anticancer Res; 2011 Jan; 31(1):345-9. PubMed ID: 21273622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin and 'melanoma inhibitory activity': comparison of two serological tumor markers in metastatic uveal melanoma patients.
    Haritoglou I; Wolf A; Maier T; Haritoglou C; Hein R; Schaller UC
    Ophthalmologica; 2009; 223(4):239-43. PubMed ID: 19270465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study.
    Reiniger IW; Wolf A; Welge-Lüssen U; Mueller AJ; Kampik A; Schaller UC
    Am J Ophthalmol; 2007 Apr; 143(4):705-7. PubMed ID: 17386288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 as a predictive biomarker for metastatic uveal melanoma in humans.
    Frenkel S; Zloto O; Pe'er J; Barak V
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):490-3. PubMed ID: 23197685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma inhibitory activity: a novel serum marker for uveal melanoma.
    Schaller UC; Bosserhoff AK; Neubauer AS; Buettner R; Kampik A; Mueller AJ
    Melanoma Res; 2002 Dec; 12(6):593-9. PubMed ID: 12459649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
    Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
    Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
    Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the behavior of uveal melanoma in the liver.
    Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ocular and metastatic uveal melanoma in an animal model.
    Blanco PL; Marshall JC; Antecka E; Callejo SA; Souza Filho JP; Saraiva V; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4376-82. PubMed ID: 16303923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
    Ma D; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways mediating liver metastasis in patients with uveal melanoma.
    Bakalian S; Marshall JC; Logan P; Faingold D; Maloney S; Di Cesare S; Martins C; Fernandes BF; Burnier MN
    Clin Cancer Res; 2008 Feb; 14(4):951-6. PubMed ID: 18281525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2).
    Hendler K; Pe'er J; Kaiserman I; Baruch R; Kalickman I; Barak V; Frenkel S
    Anticancer Res; 2011 Jan; 31(1):351-7. PubMed ID: 21273623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
    Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
    Zuidervaart W; Hensbergen PJ; Wong MC; Deelder AM; Tensen CP; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):786-93. PubMed ID: 16505008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
    Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
    Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
    Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
    Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
    Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction.
    Tobal K; Sherman LS; Foss AJ; Lightman SL
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2622-5. PubMed ID: 8344785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.